Return of Individual-Specific Research Results Generated in Research Laboratories

The NIH, in collaboration with the FDA, and CMS has announced the launch of a study by the National Academies of Sciences, Engineering, and Medicine that will convene a committee to review and evaluate the return of individual-specific research results from research laboratories, which are required to be returned in accordance with the Clinical Laboratory Improvement Amendments of 1988 (CLIA).

Find out more by checking out the National Academies' webpage on the study.